Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Floor J. Backes"'
Autor:
Shamshad Ali, Paul DiSilvestro, Russell J. Broaddus, Louise A. Brinton, Feng Gao, Shashikant Lele, Matthew A. Powell, David G. Mutch, Richard J. Zaino, David E. Cohn, Alexis Chassen, Paul J. Goodfellow, Caroline C. Billingsley, Heather A. Lankes, Colin C. Pritchard, Michael L. Pearl, Nilsa C. Ramirez, Amy P. Schmidt, Lisa M. Landrum, Luke V. Simmons, Floor J. Backes, Melissa A. Geller, Heather Hampel
Publikováno v:
Journal of Clinical Oncology
Purpose The best screening practice for Lynch syndrome (LS) in endometrial cancer (EC) remains unknown. We sought to determine whether tumor microsatellite instability (MSI) typing along with immunohistochemistry (IHC) and MLH1 methylation analysis c
Autor:
Ritu Salani, Hibaq Loyan, Jennifer Moon, Kristin Bixel, David E. Cohn, Floor J. Backes, Juan Peng, Michelle J. Naughton, Electra D. Paskett, Cecilia R. DeGraffinreid, David M. O'Malley
Publikováno v:
Journal of Clinical Oncology. 37:e18299-e18299
e18299 Background: Unreported symptoms during cancer treatment can lead to poorer patient care and quality of life. Newer technology enables effective means to track patients’ health in real time. We evaluated the feasibility of implementing system
Autor:
Ignace Vergote, Kathleen N. Moore, Dana M. Chase, Robert L. Coleman, John Balser, Paul DiSilvestro, Ofer Lavie, Gilles Freyer, Klaus Baumann, Floor J. Backes, Antonio González-Martín, Shefali Agarwal, Bradley J. Monk, Mathias Fehr, Thomas J. Herzog, Bhavana Pothuri, Domenica Lorusso, Roisin E. O'Cearbhaill, Mansoor Raza Mirza
Publikováno v:
Journal of Clinical Oncology. 34:TPS5606-TPS5606
TPS5606Background: Niraparib is a highly selective PARP1/2 inhibitor that induces synthetic lethality in tumor cells with homologous recombination DNA repair deficiencies (HRD). Niraparib is admini...
Autor:
Samuel N. Jacobson, Quan Li, Erinn M. Hade, David E. Cohn, Caroline C. Billingsley, Larry J. Copeland, A. Crim, Floor J. Backes, Ritu Salani, Sarah M. Crafton, David M. O'Malley, Jeffrey M. Fowler
Publikováno v:
Journal of Clinical Oncology. 32:5569-5569
5569 Background: The safety of the timing of pegfilgrastim administration in women with gynecologic malignancies has been questioned. We aimed to assess the safety and efficacy of administration of...